Q1 2020 G1 Therapeutics Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the G1 Therapeutics First Quarter 2020 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host today, Mr. Jeff Macdonald. Please go ahead, sir.
Thank you, Angela. Good afternoon, everyone, and welcome to the G1 Therapeutics First Quarter 2020 Corporate Financial update. On today's call, Mark Velleca, Chief Executive Officer; Raj Malik, Chief Medical Officer and Senior Vice President R&D; and Jen Moses, Chief Financial Officer, will provide an overview of the quarter with Q&A to follow-up.
Before we begin, I'd like to remind you that this call will include forward-looking statements based on current expectations, such statements represent management's judgment as of today and may involve risks and uncertainties that could cause actual results to differ materially from expected results. Please
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |